The use of nanomaterials in such things as tissue engineering devices, implants, and biosensors is growing. This book is the first to assess their risk, detailing how the body’s cells and tissues cope with the implanting of nanomaterials.
"synopsis" may belong to another edition of this title.
"Environmental safety and health has become an existential issue for the nanotechnology movement, and the international community is responding to this challenge with major multi-disciplinary research efforts. This compilation covers both the toxicology and biomedical applications of nanomaterials in a form that will be a useful reference and starting point for people working in or entering this rapidly growing field."
--Dr. Robert Hurt, Director, The Institute for Molecular and Nanoscale Innovation (IMaNI) at Brown University, Professor, Brown University, Providence, RI 02917 USA
In spite of the potential use of nanomaterials as tissue engineering devices, implants, biosensors, drug delivery devices, etc., there has yet to be a compilation of the risks associated with the in vivo use of nanomaterials. There are numerous and well-known risks because of the size of nanoparticles. For example, nanoparticles can cross cell membranes and enter the cytoplasm undetected. The aim of this book is to provide one of the first detailed overviews of how cells and tissues in the body deal with nanoparticles. This is important not only for implantable devices, but also for the manufacturing of nanophase materials when particles can be inhaled or enter the body through the skin. Only by compiling research at the intersection of nanoparticles and biological processes can we determine if nanophase materials are safe to be manufactured, handled, and/or implanted for various medical applications.
From the reviews:
"This book provides an interdisciplinary background, a valuable reference source, and a concise summary of the state of the art of various aspects of the field... While collectively covering some of the broad issues, each article provides details of specific nanoparticles, interactions, or applications." – Hugh J. Byrne, Analytical and Bioanalytical Chemistry, September, 2009
"About this title" may belong to another edition of this title.
Shipping:
US$ 24.63
From Germany to U.S.A.
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In spite of the potential use of nanomaterials as tissue engineering devices, implants, biosensors, drug delivery devices, etc., there has yet to be a compilation of the risks associated with the in vivo use of nanomaterials. There are numerous and well-known risks because of the size of nanoparticles. For example, nanoparticles can cross cell membranes and enter the cytoplasm undetected.The aim of this book is to provide one of the first (if not the first) detailed views of how cells and tissues in the body deal with nanoparticles. This is important not only for implantable devices, but also for the manufacturing of nanophase materials when particles can be inhaled or enter the body through the skin. Only by compiling research at the intersection of nanoparticles and biological processes can we determine if nanophase materials are safe to be manufactured, handled, and/or implanted for various medical applications. 252 pp. Englisch. Seller Inventory # 9781441926920
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. First detailed presentation of a key issue in nanotechnology and nanomedicineOf interest to researchers in both nanotechnology/nanomaterials and medicinePresents safety issues as an outgrowth of research into cellular responses to nanoparti. Seller Inventory # 4173191
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - In spite of the potential use of nanomaterials as tissue engineering devices, implants, biosensors, drug delivery devices, etc., there has yet to be a compilation of the risks associated with the in vivo use of nanomaterials. There are numerous and well-known risks because of the size of nanoparticles. For example, nanoparticles can cross cell membranes and enter the cytoplasm undetected.The aim of this book is to provide one of the first (if not the first) detailed views of how cells and tissues in the body deal with nanoparticles. This is important not only for implantable devices, but also for the manufacturing of nanophase materials when particles can be inhaled or enter the body through the skin. Only by compiling research at the intersection of nanoparticles and biological processes can we determine if nanophase materials are safe to be manufactured, handled, and/or implanted for various medical applications. Seller Inventory # 9781441926920
Book Description Paperback. Condition: Brand New. 1st edition. 239 pages. 8.75x6.00x0.50 inches. In Stock. Seller Inventory # zk1441926925